Mechanisms of transformation by MLL

被引:72
作者
Hess, JL [1 ]
机构
[1] Univ Penn, Sch Med, Dept Pathol & Lab Med, Stellar Chance Labs 413B, Philadelphia, PA 19104 USA
来源
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION | 2004年 / 14卷 / 04期
关键词
mixed-lineage leukemia; Hox genes; histone methylation; multiple endocrine neoplasia;
D O I
10.1615/CritRevEukaryotGeneExpr.v14.i4.10
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Rearrangements of the mixed-lineage leukemia gene MLL1 (MLL, HRX, ALL1), the human homologue of the Drosophila gene trithorax, are associated with aggressive acute leukemias in both children and adults. Transformation by rearranged forms of MLL1, including in-frame fusion proteins, partial tandem duplications, and amplification of MLL1 through upregulation of Hox gene and cofactor expression apparently results in a block in hematopoietic differentiation. MLL1 regulates Hox gene expression via direct promoter binding and histone H3 Lys 4 methylation mediated by the intrinsic methyltransferase activity of the SET domain. Mll1 knockout leads to loss of Hox gene expression, defects in hematopoiesis, and embryonic lethality. A close homologue, MLL2 is amplified in some solid tumors. MLL2 also has histone H3 Lys 4 methyltransferase activity that is dependent on menin, a protein mutated in multiple neoplasia type 1 (MEN1) and which is required for normal Hox expression. These findings underscore the importance of the MLL histone methyltransferases in development and disease.
引用
收藏
页码:235 / 254
页数:20
相关论文
共 117 条
[21]   A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL [J].
DiMartino, JF ;
Miller, T ;
Ayton, PM ;
Landewe, T ;
Hess, JL ;
Cleary, ML ;
Shilatifard, A .
BLOOD, 2000, 96 (12) :3887-3893
[22]   Tumorigenesis in mice with a fusion of the leukaemia oncogene MII and the bacterial lacZ gene [J].
Dobson, CL ;
Warren, AJ ;
Pannell, R ;
Forster, A ;
Rabbitts, TH .
EMBO JOURNAL, 2000, 19 (05) :843-851
[23]   The MII-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis [J].
Dobson, CL ;
Warren, AJ ;
Pannell, R ;
Forster, A ;
Lavenir, I ;
Corral, J ;
Smith, AJH ;
Rabbitts, TH .
EMBO JOURNAL, 1999, 18 (13) :3564-3574
[24]   Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics:: A study of the acute myeloid leukemia study group Ulm [J].
Döhner, K ;
Tobis, K ;
Ulrich, R ;
Fröhling, S ;
Benner, A ;
Schlenk, RF ;
Döhner, H .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) :3254-3261
[25]   MLL amplification in myeloid malignancies:: clinical, molecular, and cytogenetic findings [J].
Dolan, M ;
McGlennen, RC ;
Hirsch, B .
CANCER GENETICS AND CYTOGENETICS, 2002, 134 (02) :93-101
[26]  
Dorrance AM, 2003, BLOOD, V102, p132A
[27]  
Downing J R, 1996, Cancer Treat Res, V84, P73
[28]   Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans [J].
Doyon, Y ;
Selleck, W ;
Lane, WS ;
Tan, S ;
Cöté, J .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (05) :1884-1896
[29]   The small oligomerization domain of gephyrin converts MLL to an oncogene [J].
Eguchi, M ;
Eguchi-Ishimae, M ;
Greaves, M .
BLOOD, 2004, 103 (10) :3876-3882
[30]   MLL fusion partners AF4 and AF9 interact at subnuclear foci [J].
Erfurth, F ;
Hemenway, CS ;
de Erkenez, AC ;
Domer, PH .
LEUKEMIA, 2004, 18 (01) :92-102